Comparison of early clinical and optical quality-related outcomes after SMILE using VisuMax 800 versus VisuMax 500 for myopia and low-to-moderate astigmatism in a Chinese population: a single-center retrospective study - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Evaluation of Initial Clinical Outcomes and Optical Quality Metrics Following SMILE with VisuMax 800 Compared to VisuMax 500 for Myopia and Low-to-Moderate Astigmatism in a Chinese Cohort: A Retrospective Single-Center Analysis
To compare early clinical outcomes, centration accuracy, and optical quality-related parameters after SMILE performed using the VisuMax 800 and VisuMax 500 platforms in a Chinese population with myopia and low-to-moderate astigmatism.
Approach:
Key Findings:
No significant differences in uncorrected or corrected distance visual acuity, safety index, or efficacy index between groups (p > 0.05).
SMILE Pro group had significantly shorter lenticule creation time (9.47 s vs. 27.43 s, p < 0.01).
Lower absolute Y-axis decentration and total optical zone decentration in the SMILE Pro group (both p < 0.01).
Lower postoperative vertical coma in the SMILE Pro group (p = 0.004).
Lower postoperative residual cylindrical error in the SMILE Pro group (p = 0.048).
Interpretation:
Both VisuMax 500 and VisuMax 800 platforms showed favorable safety and efficacy for correcting myopia and low-to-moderate astigmatism, with the SMILE Pro platform demonstrating improved centration and optical quality metrics.
Limitations:
Retrospective design may introduce selection bias.
Single-center study limits generalizability.
Short follow-up period of 3 months.
Conclusion:
SMILE Pro (VisuMax 800) is associated with improved outcomes compared to conventional SMILE (VisuMax 500), warranting further prospective, multicenter studies with larger sample sizes and longer follow-up.